Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation
Sharat Chandra, Shanmuganathan Chandrakasan, Blachy J. Dávila Saldaña, Jack Bleesing, Michael B. Jordan, Ashish Kumar, Michael Grimley, Christa Krupski, Stella M. Davies, Pooja Khandelwal, Rebecca Marsh
Topics & Concepts
MedicineBusulfanFludarabineRegimenAlemtuzumabCumulative incidenceToxicityInternal medicineTransplantationSurgeryGastroenterologyImmunologyChemotherapyCyclophosphamideHematopoietic stem cell transplantationImmunodeficiency and Autoimmune DisordersPlatelet Disorders and TreatmentsCellular Mechanics and Interactions